These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 9824624)

  • 1. Comparative analysis of matrix metalloproteinases by immunocytochemistry, immunohistochemistry and zymography in human primary brain tumours.
    Rooprai HK; Van Meter T; Rucklidge GJ; Hudson L; Everall IP; Pilkington GJ
    Int J Oncol; 1998 Dec; 13(6):1153-7. PubMed ID: 9824624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum.
    Vaillant C; Didier-Bazès M; Hutter A; Belin MF; Thomasset N
    J Neurosci; 1999 Jun; 19(12):4994-5004. PubMed ID: 10366632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size.
    Romanic AM; White RF; Arleth AJ; Ohlstein EH; Barone FC
    Stroke; 1998 May; 29(5):1020-30. PubMed ID: 9596253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An inverse correlation between expression of NCAM-A and the matrix-metalloproteinases gelatinase-A and gelatinase-B in human glioma cells in vitro.
    Maidment SL; Rucklidge GJ; Rooprai HK; Pilkington GJ
    Cancer Lett; 1997 Jun; 116(1):71-7. PubMed ID: 9177460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory role of extracellular matrix components in expression of matrix metalloproteinases in cultured hepatic stellate cells.
    Li YL; Sato M; Kojima N; Miura M; Senoo H
    Cell Struct Funct; 1999 Oct; 24(5):255-61. PubMed ID: 15216880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of fluorometric and zymographic methods as activity assays for stromelysins and gelatinases.
    Quesada AR; Barbacid MM; Mira E; Fernández-Resa P; Márquez G; Aracil M
    Clin Exp Metastasis; 1997 Jan; 15(1):26-32. PubMed ID: 9009103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of matrix metalloproteinases and tissue inhibitor of metalloproteinases-2 in normal human and rabbit stomachs.
    Tatsuguchi A; Fukuda Y; Ishizaki M; Yamanaka N
    Digestion; 1999; 60(3):246-54. PubMed ID: 10343138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
    Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
    J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma.
    Sier CF; Kubben FJ; Ganesh S; Heerding MM; Griffioen G; Hanemaaijer R; van Krieken JH; Lamers CB; Verspaget HW
    Br J Cancer; 1996 Aug; 74(3):413-7. PubMed ID: 8695357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
    Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
    Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases MMP-2 and MMP-9 in denervated muscle and injured nerve.
    Kherif S; Dehaupas M; Lafuma C; Fardeau M; Alameddine HS
    Neuropathol Appl Neurobiol; 1998 Aug; 24(4):309-19. PubMed ID: 9775397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancer.
    Remacle AG; Noël A; Duggan C; McDermott E; O'Higgins N; Foidart JM; Duffy MJ
    Br J Cancer; 1998 Mar; 77(6):926-31. PubMed ID: 9528836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.
    Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y
    J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular extracellular matrix remodeling in cerebral aneurysms.
    Bruno G; Todor R; Lewis I; Chyatte D
    J Neurosurg; 1998 Sep; 89(3):431-40. PubMed ID: 9724118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases 2 and 9 in equine synovial fluids.
    Clegg PD; Coughlan AR; Riggs CM; Carter SD
    Equine Vet J; 1997 Sep; 29(5):343-8. PubMed ID: 9306059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of 72 kDa and 92 kDa type IV collagenases from human giant-cell tumor of bone.
    Rao VH; Bridge JA; Neff JR; Schaefer GB; Buehler BA; Vishwanatha JK; Pollock RE; Nicolson GL; Yamamoto M; Gokaslam ZL
    Clin Exp Metastasis; 1995 Nov; 13(6):420-6. PubMed ID: 7586800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of matrix metalloproteinases in human urine: alterations during adolescence.
    Thrailkill KM; Kumar S; Rosenberg CK; Auten KJ; Fowlkes JL
    Pediatr Nephrol; 1999 Apr; 13(3):223-9. PubMed ID: 10353410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 92K-GL (MMP-9) and 72K-GL (MMP-2) are produced in vivo by human oral squamous cell carcinomas and can enhance FIB-CL (MMP-1) activity in vitro.
    Pickett KL; Harber GJ; DeCarlo AA; Louis P; Shaneyfelt S; Windsor LJ; Bodden MK
    J Dent Res; 1999 Jul; 78(7):1354-61. PubMed ID: 10403463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of exogenous gangliosides on matrix metalloproteinase secretion by human glioma cells in vitro.
    Maidment SL; Merzak A; Koochekpour S; Rooprai HK; Rucklidge GJ; Pilkington GJ
    Eur J Cancer; 1996 May; 32A(5):868-71. PubMed ID: 9081368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of techniques for measurement of gelatinases/type IV collagenases: enzyme-linked immunoassays versus substrate degradation assays.
    Zucker S; Mancuso P; DiMassimo B; Lysik RM; Conner C; Wu CL
    Clin Exp Metastasis; 1994 Jan; 12(1):13-23. PubMed ID: 8287615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.